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The mouse hepatitis virus (MHV) spike glycoprotein is a major determinant of neurovirulence. We investigated how
alterations in spike affect neurovirulence using two isogenic recombinant viruses differing exclusively in spike. S4R,
containing the MHV-4 spike gene, is dramatically more neurovirulent than SA59R, containing the MHV-A59 spike gene (J. J.
Phillips, M. M. Chua, E. Lavi, and S. R. Weiss, 1999, J. Virol. 73, 7752–7760). We examined the contribution of differences in
cellular tropism, viral spread, and the immune response to infection to the differential neurovirulence of S4R and SA59R. MHV-4
spike-mediated neurovirulence was associated with extensive viral spread in the brain in both neurons and astrocytes.
Infection of primary hippocampal neuron cultures demonstrated that S4R spread more rapidly than SA59R and suggested that
spread may occur between cells in close physical contact. In addition, S4R infection induced a massive influx of lymphocytes
into the brain, a higher percentage of CD8 T cells, and a higher frequency of MHV-specific CD8 T cells relative SA59RINTRODUCTION
The severity of viral infections depends on the extent
of tissue destruction and cellular dysfunction mediated
by a combination of direct virus infection and immune-
mediated destruction. The relative contribution of these
two components differs depending on a number of virus
and host factors including viral tropism, rate of viral
spread, and specificity of the immune response.
Infection of mice with the murine coronavirus, mouse
hepatitis virus (MHV), provides a model for studying
acute virus-induced neurological disease. We have pre-
viously demonstrated that the spike (S) gene is a major
determinant of MHV neurovirulence. Recombinant vi-
ruses containing the spike gene of the highly neuroviru-
lent MHV-4 strain, S4R, exhibit a dramatically more neu-
rovirulent phenotype (3 log10 decrease in intracranial
LD50) than isogenic recombinants containing the spike
gene of the mildly neurovirulent MHV-A59 strain, SA59R
(Phillips et al., 1999). (SA59R and S4R have all other genes
derived from MHV- A59.) By defining the contribution of
direct virus-mediated pathology and immune-mediated
pathology to the differential neurovirulence of S4R and
SA59R, we can better elucidate the mechanisms by which
the MHV-4 spike confers high neurovirulence.
The MHV spike glycoprotein is required for viral entry
and spread (Boyle et al., 1987; Collins et al., 1982; Stur-
1man and Holmes, 1981). Expressed on the virion surface,
spike is responsible for binding to the viral receptor and
mediating virus–cell fusion, and subsequent to infection
spike, expressed on the host cell membrane, can medi-
ate cell–cell fusion. The spike is also vital for the immune
response to infection as it is able to induce both a
cell-mediated and a humoral-mediated immune re-
sponse (Bergmann et al., 1996; Castro and Perlman,
1995; Collins et al., 1982). Thus the high neurovirulence
conferred by the MHV-4 spike may be due to alterations
in a number of aspects of infection including viral entry,
viral spread, or the immune response to infection.
Although MHV infects many cell types in the brain,
including neurons, astrocytes, and oligodendrocytes
(Knobler et al., 1981; Lavi et al., 1984, 1988; Weiner, 1973),
it has been suggested that neuronal tropism is a major
determinant of MHV neurovirulence (Dubois-Dalcq et al.,
1982; Fleming et al., 1986; Knobler et al., 1981). The high
neurovirulence of S4R is associated with extensive
spread of virus in the brain (Phillips et al., 1999). In-
creased viral spread could either reflect increased infec-
tion of a particular cell-type, such as neurons, or alter-
natively increased infection of multiple cell types in the
CNS.
In the CNS, clearance of infectious MHV requires
multiple components of the immune response including
CD8 and CD4 T cells and B cells. Adoptive transfer
experiments in combination with depletion experiments
have demonstrated that both CD8 and CD4 T cells areinfection. Despite this robust and viral-specific immune resp
immune-mediated pathology also contributes to the high n
To whom correspondence and reprint requests should be ad-
dressed. Fax: (215) 573-4858. E-mail: weisssr@mail.med.upenn.edu.
doi:10.1006/viro.2002.1551onse to S4R infection, infection of RAG1/mice suggested that
eurovirulence of S4R. © 2002 Elsevier Science (USA)critical for normal viral clearance (Korner et al., 1991;
0042-6822/02 $35.00109 © 2002 Elsevier Science (USA)
All rights reserved.
Stohlman et al., 1986, 1995, 1998; Sussman et al., 1989;
Williamson and Stohlman, 1990; Yamaguchi et al., 1991).
Furthermore, the peak of T lymphocyte infiltration into the
CNS is coincident with falling titers of infectious virus in
the CNS (Williamson et al., 1991). Relative to infection
with SA59R, infection with S4R results in a dramatic infil-
tration of inflammatory cells into the CNS (Phillips et al.,
1999). Differences in either the composition of these
infiltrates or their virus-specific activity could have a
profound influence on neurovirulence.
The MHV spike is a major determinant of MHV neu-
rovirulence. To identify the critical parameters of infec-
tion mediating the differential neurovirulence of S4R and
SA59R, we characterized the cellular tropism and compo-
sition and function of the lymphocytic response to infec-
tion with S4R and SA59R. Our results suggest that the high
neurovirulence conferred by alterations in the MHV spike
are mediated by both increased viral spread in multiple
cell types in the brain and immune-mediated pathology.
RESULTS
S4R and SA59R exhibit similar cellular tropism
We previously observed that at the peak of virus rep-
lication, day 5 postinfection, the more neurovirulent S4R
infects a significantly greater number of cells in the basal
FIG. 1. Identification of S4R- and SA59R-infected neurons in the brain 5 days after intracranial inoculation. Representative pictures are shown of
double-immunofluorescent labeling of sagittal brain sections taken from S4R-inoculated (A and B), and SA59R-inoculated (C and D) mice. A and C show
immunofluorescent labeling of viral antigen in the basal forebrain (red). B and D show the corresponding labeling of MAP2b in neurons (green). Note
MAP2b-positive cells exhibit the characteristic morphology of neurons. Arrows identify cells double-positive for viral antigen, and MAP2b in both S4R and
SA59R inoculated brains. Note the greater total number of viral antigen-positive cells following inoculation with S4R. No viral antigen staining was observed
in mock-infected mice, when sections were incubated in preimmune sera, or when the primary antibody was omitted (data not shown). Magnification,380.
FIG. 2. Quantification of viral antigen positive cells in the brain
following inoculation with S4R and SA59R. The total number of viral
antigen-positive cells per brain section following infection with S4R
(open squares), and SA59R (open diamonds) was determined on days 3
and 5 postinfection. On day 5 postinfection two brain sections per
mouse were examined, and the mean number of viral antigen-positive
cells per sagittal section was determined (n  5). For the quantification
of viral antigen-positive cells on day 3 a single sagittal section was
examined for each infected mouse (n  4). The mean number of viral
antigen-positive cells per brain section (horizontal line) following infec-
tion with S4R was significantly greater than with SA59R on days 3 and 5
postinfection (two-tailed t test, P  0.05, and P  0.001, respectively).
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forebrain, hippocampus, and cingulate gyrus than SA59R
(Phillips et al., 1999). Increased infection could reflect
differences in viral spread in a single cell type or in
multiple cell types. To quantitatively compare the cellular
tropism of S4R and SA59R, we performed double-label
immunofluorescence on sagittal brain sections for viral
TABLE 1
Identification of CNS Cells Infected by S4R and SA59R on Day 5 Postinfection
a
Virus Animal
Section 1 Section 2
No. of viral
antigen-positive cells
No. of cells
double-positive with AP14 (%)b
No. of viral
antigen-positive cells
No. of cells
double-positive for GFAP (%)b
S4R 1 599 328 (54.8) 478 132 (27.6)
2 1016 493 (48.5) 1096 111 (10.1)
3 883 469 (53.1) 765 148 (19.3)
4 1192 597 (50.1) 713 202 (28.3)
5 249 143 (57.4) 738 99 (13.4)
Group mean (52.8) Group mean (19.7)
SA59R 1 529 291 (55.0) 288 61 (21.2)
2 97 52 (53.6) 330 44 (13.4)
3 239 134 (56.1) 259 37 (14.3)
4 403 208 (51.6) 616 170 (27.6)
5 326 163 (50.0) 282 80 (28.4)
Group mean (53.3) Group mean (21.0)
a Mice were inoculated intracranially with 10 PFU of either S4R or SA59R. Animals were sacrificed on day 5 postinfection and perfused, and the brain
was fixed in formalin, embedded in paraffin, and sectioned sagittally. Section 1 and 2 are adjacent.
b The slides were double-immunostained with anti-MHV-A59 serum and AP14, a monoclonal antibody to MAP2b, or a mouse anti-GFAP antibody.
Sagittal sections were coded and systematically examined in a blinded fashion (magnification 190), and the total number of viral antigen-positive
cells and double-positive cells per section was determined. The (%) is the percentage of the total number of viral antigen positive cells counted that
were also positive for the indicated marker.
FIG. 3. Viral spread in primary hippocampal neuron cultures. Neurons were cultured for 4 days and then infected with S4R (A and B) or SA59R (C
and D). Representative pictures on day 3 postinfection are shown. Colocalization of viral antigen (A and C) and neuronal cell markers (B and D) were
demonstrated using double-immunofluorescence for viral antigen (green) and MAP2 (red). The arrows indicate viral antigen-positive neurons, while
the arrowheads indicate viral antigen-positive neurites. Note the large focus of viral antigen-positive cells following infection with S4R (A).
Magnification, 190.
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antigen and MAP2b, a neuron-specific marker (De Cam-
illi et al., 1984; Riederer et al., 1995), or glial fibrillary
acidic protein (GFAP), an astrocyte-specific marker. Mice
were inoculated intracranially with 10 PFU of S4R or SA59R
and animals were sacrificed at 3 and 5 days postinfec-
tion.
The sections were systematically scanned (magnifica-
tion, 190) in a blinded fashion, and the total number of
viral antigen-positive and double-positive cells was de-
termined. Representative pictures of double-immunoflu-
orescence for viral antigen and MAP2b are shown (Fig.
1). On days 3 and 5 postinfection, the mean number of
viral antigen-positive cells per brain section was signif-
icantly greater following infection with S4R than SA59R
(two-tailed t test, day 3, P  0.05, and day 5, P  0.001)
(Fig. 2). The pattern of viral antigen expression in the
brain was similar following infection with S4R or SA59R.
Despite the difference in the absolute number of in-
fected cells, S4R had a similar cellular tropism as SA59R.
As shown in Table 1, we found that the percentage of
viral antigen-positive cells that were also positive for
neuronal or astrocytic markers was remarkably similar
for S4R and SA59R. On day 5 postinfection, neurons ap-
peared to account for approximately 53% of either S4R- or
SA59R-infected cells, while astrocytes accounted for ap-
proximately 20 or 21% of S4R- or SA59R-infected cells,
respectively. Thus the increased neurovirulence of S4R
correlated with increased infection of multiple CNS cell-
types, including both neurons and astrocytes.
Viral spread of S4R and SA59R differs in primary
neuronal cultures
The extent of neuronal infection is thought to be a
determinant of MHV neurovirulence (Dubois-Dalcq et al.,
1982; Fleming et al., 1986; Knobler et al., 1981). As an in
vitro model of CNS infection and to examine the ability of
S4R and SA59R to spread in neurons, we infected primary
hippocampal neuron cultures obtained from B6 mice
with the two viruses. Immunostaining for MAP2 and
GFAP demonstrated that the cultures consisted primarily
of neurons with less than 8% of the cells exhibiting GFAP
immunoreactivity (data not shown). On days 0, 1, and 3
after infection, supernatants were titered for infectious
virus and the number of viral antigen-positive cells was
determined by immunofluorescence. Neurons did not
exhibit cytopathic effect for the duration of the experi-
ment as assessed by bright-field microscopy.
To compare the number of cells infected with each
virus, we used immunofluorescence to detect viral anti-
gen expression. S4R and SA59R infection of neurons was
confirmed by cell morphology and by double-immunos-
taining for viral antigen and MAP2 (Fig. 3). Viral antigen-
positive cells were often located in discrete foci. More-
over, viral antigen-positive neurites could often be ob-
served between infected cells or between foci of infected
cells, suggesting that perhaps one means of viral spread
in these cultures was along neurites. To examine the
pattern of viral spread in these cultures, we determined
the total number of viral antigen-positive cells and the
total number of foci of infected cells per coverslip at
different time points (Table 2). On day 1 postinfection the
average number of foci and the total number of antigen-
positive cells was similar following infection with S4R
and SA59R. On day 3 postinfection, although the average
number of foci was similar, the average number of viral
antigen-positive cells was significantly greater following
infection with S4R than SA59R (two-tailed t test, P  0.01).
Thus, on day 3 the number of viral antigen-positive cells
per focus was greater for S4R, 5.79  1.15, than SA59R,
3.17 1.59 (mean SD). The difference in the number of
infected cells, despite a similar number of foci, between
S4R and SA59R, suggested that S4R spread faster via
cell–cell spread than SA59R. Thus, the results in primary
neuronal cultures were consistent with the results in vivo
and suggested that the MHV-4 spike conferred an inher-
ent ability to spread rapidly from cell to cell in the CNS.
Consistent with previous studies in which primary neu-
ronal cultures were infected with MHV (Dubois-Dalcq et al.,
1982; Pasick et al., 1994), the amount of infectious virus
released into the media was minimal. Following infection
with S4R or SA59R, the titers of infectious virus in the super-
natants initially dropped, day 0 to day 1 postinfection, and
then remained the same from day 1 to day 3 postinfection
(Table 2). The inactivation of infectious virus in the residual
inoculum most likely accounted for the precipitous drop in
TABLE 2
S4R and SA59R Infection of Primary Neuronal Cultures
a
Virus Day
Viral titers log
(PFU/mL)
mean  SDb
No. of foci
mean  SDc
No. of viral
antigen-positive
cells mean  SDd
S4R 0 3.79 0.39 0 0
1 2.13 0.34 60 17 367 108
3 2.28 0.22 127 52 842 31
SA59R 0 4.21 0.12 0 0
1 3.59 0.15 122 79 302 165
3 3.38 0.19 162 34 471 109
a Primary hippocampal neuron cultures were infected on day 4 post-
explant at an m.o.i. of 5. Coverslips containing infected neurons were
fixed in 2% paraformaldehyde and immunostained for viral antigen
(mouse antinucleocapsid).
b Supernatants from infected cultures were collected at the indicated
times and viral titers were determined on L2 cells. The titers are the
mean titers from two independent experiments (n  6).
c A group of viral antigen-positive cells that appeared to exhibit
cell–cell contact was defined as a focus. The data shown represent the
results from two independent experiments (n  4).
d The total number of viral antigen-positive cells per coverslip was
determined (n  4, except on day 3 following infection with S4R, n 
3). On day 3 the mean number of viral antigen-positive cells was
greater following infection with S4R than SA59R (two-tailed t test, P 
0.01).
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viral titers from day 0 to 1 postinfection. On days 1 and 3, the
titers of infectious virus were lower in S4R-infected cultures
than SA59R-infected cultures.
Differences in the composition of the lymphocytic
response to infection with S4R and SA59R
The MHV-4 spike appears to mediate more efficient
spread in cells of the CNS than the MHV-A59 spike.
Previously we observed a difference in the immune re-
sponse to infection with S4R and SA59R by H&E staining.
S4R infection induced a greater infiltration of inflamma-
tory cells into the brain than SA59R infection (Phillips et al.,
1999). The immune response to MHV infection is com-
plex, and multiple components of the immune response
are required for optimal clearance of infectious virus
from the CNS. Therefore, both quantitative and qualita-
tive differences in the antiviral immune response may
also contribute to the differential neurovirulence of S4R
and SA59R.
We used flow cytometry to quantitatively compare the
composition of the immune response in the brain to
infection with S4R and SA59R. Total brain mononuclear
cells were isolated on days 5 and 7 postinfection and
were examined for surface expression of CD45 (a marker
of nucleated cells of hematopoietic lineage), CD8, CD4,
and B220.
At the peak of inflammation, day 7 postinfection, the
difference in the total number of inflammatory cells in the
brain between S4R and SA59R was dramatic. The number
of immune cells, as determined by CD45 positivity, iso-
lated from each brain following S4R and SA59R infection
was between 1.2  106 and 1.1  107 cells and was on
average fivefold greater following infection with S4R than
SA59R. Representative data are shown in Fig. 4. Flow
analysis of brain-derived lymphocytes revealed that the
percentage of CD8 T cells was also greater following
infection with the more neurovirulent S4R as compared
with SA59R (Fig. 4B). In contrast, the percentage of cells
positive for CD4 or B220 (a B cell marker) was similar
following infection with S4R and SA59R. We next examined
the ratio of CD8 to CD4 T cells for S4R and SA59R from
four independent experiments. The mean ratio of CD8
to CD4 T cells following infection with S4R, 2.83  0.26
(mean  SEM), was significantly greater than the ratio
following infection with SA59R, 1.73  0.06 (mean  SEM)
(two-tailed t test, P  0.01) (n  4). Due to the difference
in total cells isolated per brain, the estimated numbers of
CD45, CD4, CD8, and B220 cells per mouse brain
were between three- and fivefold greater following infec-
tion with S4R than with SA59R (Fig. 4C). Thus, the high
neurovirulence of S4R relative to SA59R was correlated
with a greater total number of mononuclear cells in the
brain, and a significant increase in the percentage of
CD8 T cells.
On day 5 following infection with either S4R or SA59R,
the magnitude of the inflammatory response to infection
in the brain was much less than on day 7 postinfection
as previously observed by Haring et al. (2001) and Wil-
liamson et al. (1991). In addition, the numbers of CD8 or
CD4 T cells in the brain were just above the level of
detection. Even on day 5 postinfection, however, the
number of immune cells in the brain following infection
with S4R was still greater than following SA59R infection
(data not shown).
Functional differences in the T cell response to
infection with S4R and SA59R
In addition to differences in the magnitude and in the
composition of the immune response to infection with S4R
and SA59R, we hypothesized that there might be differences
in the function of MHV-specific T cells. To compare the
frequency of functionally activated, MHV-specific CD8 and
CD4 T cells in the CNS following infection with S4R or
SA59R, we performed intracellular IFN- assays. Brain-de-
rived T cells on day 7 postinfection were isolated and
challenged with peptides containing the immunodominant
or sub-immunodominant CD8 T cell epitope, S510 or S598,
or the immunodominant CD4 T cell epitope, M133, and
stained for intracellular IFN- as described previously (Mu-
rali-Krishna et al., 1998).
Representative results are shown in Fig. 5. Following
S4R infection, approximately 13.6 and 9.3% of the CD8
 T
cell population in the CNS was S510-specific and S598-
specific, respectively. S510 and S598 are the only two
known CD8 T cell epitopes for MHV; therefore, the total
frequency of MHV-specific CD8 T cells in the CNS
following S4R infection was approximately 22.9%. The
MHV-A59 spike lacks the immunodominant S510 epitope
(Luytjes et al., 1987). Thus, following infection with SA59R
the MHV-specific CD8 T cell response was S598-spe-
cific and accounted for approximately 11.8% of the CD8
T cell response.
Within the population of cells isolated from the CNS, a
proportion of CD4 cells exhibited intracellular IFN- in
the absence of peptide (Fig. 5B). The reason for this
background level of IFN- expression is not known; how-
ever, it has been suggested that infected microglia and
macrophages in the CNS cell preparation may stimulate
CD4 T cells (Haring et al., 2001). The frequency of
M133-specific CD4 T cells following infection with S4R
or SA59R was similar, accounting for approximately 16.0
and 15.4% of the CD4 T cell response, respectively. As
this may overestimate the frequency of MHV-specific
cells in the CNS, we also subtracted the percentage of
IFN--expressing cells in the absence of peptide from
the total percentage of IFN--expressing cells after pep-
tide stimulation. The calculated frequency of M133-spe-
cific CD4 T cells following infection with S4R, 10.6%, and
SA59R, 8.9%, was also similar. Thus, infection with either
S4R or SA59R resulted in a robust CD8
 and CD4 T cell
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response that was both epitope-specific and functional.
The major difference between the frequency of virus-
specific T cells induced by S4R and SA59R was the in-
creased frequency of functionally activated CD8 T cells
following infection with the more neurovirulent S4R. Note
that due to the increased numbers of inflammatory cells
in the brain following S4R infection relative to SA59R in-
fection, the total number of virus-specific CD8 and
CD4 T cells in the brain was greater following infection
with S4R than SA59R.
Contribution of lymphocytes to differential
neurovirulence
S4R infection resulted in a greater number of lympho-
cytes and a higher frequency of virus-specific immune
FIG. 4. Lymphocyte populations in the brain following inoculation with S4R and SA59R. Mice were infected with S4R or SA59R and animals were
sacrificed at the peak of inflammation, day 7 postinfection. (A) The upper row depicts the forward scatter and side scatter characteristics of
representative mononuclear cell preparations from the brains of S4R- and SA59R-infected mice. Surface expression of CD45 was used to assist in the
gating of mononuclear cells, and representative flow cytometry density plots showing expression of CD45 (x-axis) and CD8 (y-axis) in S4R-infected
mice (left lower row) and SA59R-infected mice (right lower row). Numbers in the upper right quadrants represent the percentage of CD8
 CD45
monocytes, and the numbers in the right lower quadrant represent the percentage of CD8 CD45 monocytes. (B) Relative percentages of CD8,
CD4, and B220 cells in brain-derived monocytes. (C) Absolute numbers of total cells, CD45, CD8, CD4, and B220 cells in cell preparations
from the brain. Mononuclear cell preparations from six mice were pooled, and the results are representative of four independent experiments. A
smaller number of cells (6.6  105 cells per brain) were obtained from mock-infected mice with only 4% of these CD45.
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cells in the CNS than SA59R infection. To evaluate the
contribution of lymphocytes to the differential neuroviru-
lence observed with S4R and SA59R, we compared the
survival of infected RAG1/ mice (B6 background),
which lack functional T and B cells (Mombaerts et al.,
1992), and immunocompetent B6 mice. RAG1/ mice
infected with SA59R experienced 100% mortality while
immunocompetent mice survived following challenge
with SA59R (Fig. 6A). Thus, SA59R-infected immunocompe-
tent B6 mice are protected from death by the activated
immune response, and without this response the mice
succumb to a lethal infection. In contrast, RAG1/
mice infected with S4R exhibited prolonged survival rel-
ative to immunocompetent B6 mice: the median survival
time for S4R-infected mice was 13 days in RAG1/ and
10 days in B6 mice (statistically different, Mann–Whitney
rank sum test, P 0.0001) (Fig. 6B). Prolonged survival in
S4R-infected RAG1/ mice suggested that T or B cells
contributed to pathology.
We examined virus titers in the brain and other organs
of RAG1/ mice. At five days postinfection, the titers of
infectious virus in the brains of RAG1/ mice were
similar to those in B6 mice, following SA59R infection 6.0
vs 5.4 and following S4R infection 5.1 vs 5.1 [log10(PFU/g)]
(n 2), respectively. In addition, similar to the infection in
immunocompetent mice the level of infectious virus was
minimal in the liver and undetectable in the spleen,
kidney, lung, heart, and a portion of the small intestine
FIG. 5. MHV-specific CD8 and CD4 T cells following infection with S4R and SA59R. Mononuclear cells were isolated from the brain of S4R- and
SA59R-infected mice on day 7 postinfection, and the frequency of CD8
 and CD4 T cells specific for MHV-specific epitopes were determined by
intracellular IFN- staining. Cells were cultured with or without peptide as indicated above each column. The numbers in the upper right quadrants
indicate the percentage of CD8 T cells (A) or CD4 T cells (B) that are positive for the intracellular IFN- stain following infection with either S4R
(top row) or SA59R (bottom row). The numbers in the right lower quadrants represent the percentage of CD8
 T cells (A) or CD4 T cells (B) that are
negative for the intracellular IFN- stain. Brain mononuclear cells were pooled from six to eight animals, and these data are representative of two
to five experiments.
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(data not shown). Unlike B6 mice, which clear infectious
virus early in infection, by day 13 postinfection with S4R
or SA59R there were high levels of infectious virus in the
brain. Infectious virus remained localized to the CNS
following S4R infection, but mice infected with SA59R had
high titers of virus in the spleen and liver at late times
postinfection (data not shown). Thus, following infection
with SA59R the acquired immune response was critical for
viral clearance in the brain, protection from viral spread
to other organs, and protection from subsequent death.
In contrast, S4R-infected RAG1/ mice displayed pro-
longed survival despite persistent, high titers of infec-
tious virus in the CNS, suggesting that immune-mediated
pathology may contribute to the highly neurovirulent phe-
notype of S4R.
DISCUSSION
The spike glycoprotein is a major determinant of MHV
neurovirulence. We examined how alterations in spike
affect neuropathogenesis using S4R and SA59R, two iso-
genic recombinant viruses that differ exclusively in spike.
To identify the parameters of MHV infection mediated by
spike and important in neurovirulence, we compared the
cellular tropism of S4R and SA59R and both quantitative
and functional features of the immune response to infec-
tion. Our studies suggest that differences in viral spread
in multiple cell types, differences in the magnitude of the
immune response to infection, and immune-mediated
pathology contribute to the differential neurovirulence of
S4R and SA59R. We have shown previously (Phillips et al.,
1999, 2001) that, during acute infection, the titers of
infectious virus in the brains of animals infected with S4R
and SA59R are similar. Thus, the spread of viral antigen,
neurovirulence, and mortality are not determined by the
level of infectious virus in the CNS.
Neuronal infection has been proposed to be a major
determinant of MHV neurovirulence (Dubois-Dalcq et al.,
1982; Fleming et al., 1986; Knobler et al., 1981). Using
double-immunohistochemistry, we quantitatively com-
pared the tropism of S4R and SA59R for neurons and
astrocytes. We determined that on days 3 and 5 postin-
fection, S4R infected a greater total number of cells than
SA59R throughout the brain. Despite the difference in viral
spread, however, the tropism of S4R and SA59R for neu-
rons and astrocytes was identical. Thus differences in
viral spread, not differences in neuronal tropism per se,
contributed to the differential neurovirulence of S4R and
SA59R.
Despite the similarity in neuronal tropism, however,
the number of infected neurons was greater following
infection with S4R than SA59R due to the greater total
number of cells infected. To compare the ability of S4R
and SA59R to spread in cells from the CNS, we examined
the infection of primary hippocampal neuron cultures.
S4R infection of neuronal cultures resulted in greater viral
spread than SA59R infection, and the pattern of spread
suggested that S4R spreads more rapidly from cell to cell
than SA59R. Viral spread along neuronal processes could
contribute to rapid dissemination of virus to multiple
regions of the brain. Future studies will address how the
MHV-4 spike confers rapid cell to cell spread, and the
effect of infection on neuronal viability.
In addition to increased viral spread, S4R mediated a
greater influx of immune cells into the CNS than SA59R. To
identify how this increased immune response to infec-
tion might influence the differential neurovirulence of S4R
and SA59R, we compared the composition and the func-
tion of the lymphocytic response to infection. At the peak
of inflammation, day 7 after infection, the more neuro-
virulent S4R induced the infiltration of a greater number
of T cells and B cells into the CNS with a specific
increase in the percentage of CD8 T cells as compared
to SA59R.
We also compared the virus-specific activity of CD4
and CD8 T cells from the CNS of animals infected with
S4R and SA59R by measuring intracellular IFN- secretion
FIG. 6. Effect of a functional T and B cell response on mortality
following intracranial inoculation with SA59R (A) or S4R (B). B6 (open
symbols) or RAG1/ (closed symbols) mice were inoculated with 10
PFU of virus and observed daily for mortality. The percentage survival
and median time to death in days (number to right of line) is shown.
Following inoculation with S4R (B), there was a significant difference in
the median time to death between RAG1/ and B6-infected mice (13
and 10 days, respectively, Mann–Whitney rank sum test, P  0.0001).
Although not shown on the graph, all RAG1/ mice inoculated with
S4R died by 43 days postinfection. No deaths were observed in B6 mice
after 19 days postinoculation. The data shown represent the results
from two independent experiments from a total of 14 RAG1/ mice
per virus, 11 B6 mice inoculated with SA59R, and 15 B6 mice inoculated
with S4R.
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in response to specific viral epitopes. Both S4R and SA59R
induced robust and virus-specific immune responses;
however, there were differences in the specificity of the
CD8 T cell response. The two H-2b CD8 T cell epitopes
recognized in B6 mice are located in the spike glyco-
protein at residues 510–518 (S510) and 598–605 (S598)
(Bergmann et al., 1996; Castro and Perlman, 1995). A 52
amino acid deletion in the spike of MHV-A59 relative to
the spike of MHV-4 removes the more immunodominant
510–518 epitope (Luytjes et al., 1987; Parker et al., 1989).
Consistent with this difference in epitopes, the frequency
of S510-specific CD8 T cells in the CNS was high
following S4R infection and undetectable following SA59R
infection. The lack of the S510 epitope in SA59R did not
appear to induce a significantly greater immune re-
sponse to S598, however, as the frequency of S598-
specific CD8 T cells in the CNS following infection with
S4R or SA59R was similar. The two viruses also shared a
similar frequency of response to the dominant CD4 T
cell epitope (Xue and Perlman, 1997), M133, located
within the viral matrix protein.
Thus, expression of the S510 epitope was responsible
for the greatest difference in the frequencies of virus-
specific, functionally activated T cells following infection
with S4R and SA59R. S4R infection induced a greater
percentage of CD8 T cells in the CNS than SA59R infec-
tion. The response to the S510 epitope in the S4R spike
may at least partially account for this increase in the
frequency of CD8 T cells. Interestingly, mutations in the
S510 epitope in a related MHV-JHM strain have been
associated with alterations in neuropathogenesis (Pewe
et al., 1998). However there are other factors that may
contribute. For example, quantitative differences in anti-
gen presentation or differences in the ability of immune
cells to traffic to and proliferate in the CNS following
infection with S4R and SA59R may contribute to differ-
ences in the percentage of CD8 T cells and to the
overall magnitude of the antiviral immune response. Fur-
thermore the percentage of total CD8 T cells among
CNS lymphocytes (Fig. 4) may include CD8 cells spe-
cific for epitopes other than S510 and S598, perhaps host
epitopes. Future experiments will address the role of this
epitope in the differential neurovirulence of S4R and
SA59R.
To examine the role of the T and B cell response to
infection in the differential neurovirulence of S4R and
SA59R, we compared the virulence of these viruses in the
presence and absence of a functional T and B cell
response. Despite prolonged replication of infectious
S4R in the CNS of RAG/ mice, these mice exhibited
prolonged survival relative to immunocompetent mice. In
contrast, the T and B cell response to SA59R infection was
primarily protective. These data suggest that immune-
mediated pathology contributes to the high neuroviru-
lence of S4R. Interestingly, previous studies with MHV
have also suggested that, in addition to its role in pro-
tection, the inflammatory response, particularly the T cell
response, can be immunopathologic. Prolonged survival
of perforin-deficient mice infected with a JHM strain of
virus suggested that CD8 CTLs might contribute to
disease (Lin et al., 1997). Moreover, CD4 T cells have
also been implicated in immunopathology; both adoptive
transfer experiments with CD4 T cells and infection of
CD4 knockout mice have suggested that CD4 T cells
in the CNS may increase disease morbidity (Lane et al.,
2000; Wu et al., 2000). To determine whether CD8 or
CD4 T cells were primarily responsible for the pro-
longed survival in RAG/ mice, we compared the sur-
vival of CD8/, CD4/, and immunocompetent B6
mice infected with S4R; however, the absence of either T
cell subset alone did not confer significantly increased
survival (data not shown).
Previous studies have demonstrated the complexity of
the immune response to MHV and the requirement for
multiple components for clearance (Korner et al., 1991;
Stohlman et al., 1986, 1995, 1998; Sussman et al., 1989;
Williamson and Stohlman, 1990; Yamaguchi et al., 1991;
Bergmann et al., 2001). Our results suggest that MHV-
induced immunopathology is also complex and involves
multiple components of the immune response to infec-
tion. Studies with LCMV and HIV have suggested that
virus strains that exhibit rapid viral spread are asso-
ciated with increased immune-mediated pathology
(Wodarz and Krakauer, 2000; Moskophidis et al., 1995).
Future studies will delineate which components of the
immune response to S4R contribute to immunopathology
and examine how increased viral spread may induce
such a response.
Increased neurovirulence conferred by the MHV-4
spike correlates with both rapid viral spread in the CNS
and immune-mediated pathology. By studying two iso-
genic viruses with defined alterations in spike in in vivo
infections and in in vitromodels of MHV infection, we can
begin to dissect the different roles of the spike glyco-
protein in neurovirulence. Furthermore, we can examine
the contribution of virus- and immune-mediated pathol-
ogy to neurovirulence.
MATERIALS AND METHODS
Virus and cells
The recombinant viruses, referred to as S4R (contain-
ing the MHV-4 spike gene) or SA59R (containing the MHV-
A59 spike gene), were generated using targeted RNA
recombination and are in the MHV-A59 background
(Fischer et al., 1997). We have in the past described
independent isolates of both S4R (S4R22 and S4R29) and
SA59R [SA59R13 (wtR13) and SA59R16] (Phillips et al., 1999,
2001). Since the group of recombinant viruses express-
ing the MHV-4 spike gene are phenotypically indistin-
guishable from each other, they will be referred to col-
lectively as S4R; similarly, since the group of viruses
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expressing the A59 spike gene are phenotypically indis-
tinguishable from each other, they will be referred to
collectively as SA59R. All viral stocks were grown in 17Cl-1
cells, and infectious virus was quantified by plaque as-
say, using murine L2 cells as indicator cells.
Inoculation of mice
Four-week old male C57Bl/6 (B6) mice were pur-
chased from the National Cancer Institute (Bethesda,
MD), and four-week old male RAG1/ mice were pur-
chased from the Jackson Laboratory (Bar Harbor, ME).
No mature B or T lymphocytes are produced in
RAG1/ mice (Mombaerts et al., 1992). All mice were
certified MHV-free. Mice were anesthetized with Isoflu-
rane (IsoFlo; Abbott Laboratories), and injections were
performed in the left cerebral hemisphere. Each injection
contained 10 PFU of virus diluted to a volume of 20 l per
mouse in PBS containing 0.75% bovine serum albumin.
Mock-infected controls were inoculated similarly but
with an uninfected 17Cl-1 cell lysate at a comparable
dilution.
Double-label indirect immunofluorescence on brain
sections
At various times after infection with S4R or SA59R, mice
were sacrificed and perfused with 10 ml of PBS, and the
brains were removed. The right half of the brain was
fixed in Formalin for 2 days, embedded in paraffin, sec-
tioned, and left unstained for immunofluorescence. Ad-
jacent sagittal brain sections close to midline, 10–20 m
apart, were examined. Sections were blocked with 2%
goat serum in Tris–HCl and 0.1% Triton X-100 for 1 h,
incubated with primary antibodies for 2 h, and incubated
with secondary antibodies for 1 h. All incubations were
carried out in a humidified chamber at 37°C, and after
each step the sections were washed (three times for 5
min each) in PBS. For localization of viral antigen, sec-
tions were incubated with a 1:100 dilution of rabbit anti-
MHV-A59 serum, made against detergent-disrupted
MHV-A59, obtained from Mark Denison (Vanderbilt Uni-
versity, TN). Neurons were identified with a 1:50 dilution
of mouse monoclonal antibody AP14 (Geisert et al.,
1990), which recognizes the MAP2b protein (De Camilli
et al., 1984; Riederer et al., 1995), obtained from Virginia
M.-Y. Lee (University of Pennsylvania, PA). Astrocytes
were identified with a 1:50 dilution of a mouse monoclo-
nal antiglial fibrillary acidic protein (PharMingen). Rabbit
antibodies were detected with a 1:40 dilution of TRITC-
conjugated swine anti-rabbit immunoglobulins (Dako
Corp.). Murine antibodies were detected with a 1:100
dilution of biotin-conjugated horse anti-mouse immuno-
globulins followed by treatment with a 1:200 dilution of
Fluorescein Avidin D (FITC) for 30 min, purchased from
Vector Laboratories.
Control slides were incubated in parallel with preim-
mune rabbit serum, and sections from mock-infected
animals were incubated with rabbit anti-MHV-A59 serum.
For each double-immunostaining scheme, it was verified
that the secondary antibody did not bind in the absence
of the primary antibody or cross-react with primary anti-
bodies of different species.
Isolation of primary hippocampal neurons
Primary hippocampal neurons were obtained from day
14 to day 16 embryonic mice, as described previously
(Banker and Goslin, 1991; Pasick et al., 1994; Rall et al.,
1997), except the cells were maintained in neurobasal
medium (Gibco/BRL) containing 4 g/ml glutamate, in
the absence of an astrocyte feeder layer. The mice used
in these experiments were C57Bl/6 transgenic mice ex-
pressing the human MV receptor, CD46 (Rall et al., 1997).
Cells were plated at a density of 2–7  105 cells per
glass coverslip.
Infection of primary hippocampal neuron cultures and
virus detection
On day 4 postexplant, cells were infected at a multi-
plicity of infection (m.o.i.) of 5 with S4R or SA59R or mock-
infected with 17Cl-1 cell lysate. After 1 h at 37°C with
gentle agitation, the inoculum was removed; conditioned
neurobasal medium was added back to the cultures, and
the cultures were maintained at 37°C in 5% CO2 until
harvesting. In each of two independent experiments
three coverslips were infected per virus per time point.
The levels of infectious virus in the supernatants as a
function of time following infection were determined by
plaque-assay on L2 cell monolayers. For the localization
of viral antigen coverslips containing infected cells were
washed once with PBS, fixed in 1% paraformaldehyde,
and stored at 4°C. Coverslips were blocked with 2% goat
serum in Tris–HCl and 0.1% Triton X-100 for 15 min,
incubated with primary antibodies for 2 h, and incubated
with secondary antibodies for 1 h. Between each step
the coverslips were washed in Tris–HCl and 0.1% Triton
X-100 six times, and all incubations were carried out at
room temperature in a humidified chamber. To detect
viral antigen coverslips were incubated with a 1:20 dilu-
tion of mouse antinucleocapsid antibody, obtained from
Julian L. Leibowitz (Texas A&M University, TX). This was
followed by incubation with the secondary antibody, a
1:200 dilution of biotin-conjugated horse anti-mouse im-
munoglobulins (Vector Laboratories), and then incuba-
tion with a 1:200 dilution of fluorescein avidin D (FITC)
(Vector Laboratories) for 30 min. MAP2 and GFAP were
detected with a 1:300 dilution of rabbit anti-MAP2 ob-
tained from Virginia M.-Y. Lee (University of Pennsylvania,
PA) and a 1:250 dilution of rabbit anti-cow glial fibrillary
acidic protein (GFAP) (Dako Corp.), respectively. Rabbit
antibodies were detected with a 1:40 dilution of TRITC-
conjugated swine anti-rabbit immunoglobulins (Dako
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Corp.). Mock-infected coverslips were incubated in par-
allel with mouse antinucleocapsid antibodies. Coverslips
mounted on slides were blinded and systematically ex-
amined by fluorescence and bright-field microscopy
(magnification, 190 and 380).
Isolation of monocytes from the CNS
Monocytes were prepared from the CNS as previously
described by Pewe et al. (1999) on days 5 and 7 after
intracranial inoculation with 10 PFU of S4R or SA59R or
mock-infected with 17Cl-1 cell lysate. Two to six brains
were pooled per sample. In brief, animals were sacri-
ficed and perfused with 10 mL of PBS, and a single-cell
suspension from the brain was obtained by passing cells
through a nylon mesh bag (64-m pore diameter). Percoll
(Pharmacia) was added to a final concentration of 30%,
and the lysate was centrifuged at 1300 g for 30 min at
4°C. The cell pellet was resuspended, passed through a
cell strainer (pore diameter, 70 m) (Becton–Dickinson),
and washed. The cells were then layered over 2 ml
Lympholyte-M (Cedarlane Laboratories) and centrifuged
at 1300 g for 20 min at room temperature. Cells were
removed from the interface, washed once, and counted.
Flow analysis
Expression of cell-surface markers was determined by
staining cells with monoclonal antibodies specific for
CD8a (clone 53–6.7), CD4 (clone RM4-5), CD45 (leuko-
cyte common antigen, clone 30-F11), and B220 (CD45R/
B220, clone RA3-6B2) purchased from PharMingen. For
flow cytometry approximately 1 106 cells were washed
three times with PBS 1% BSA and blocked with 50 g of
rat IgG and a 1:200 dilution of anti-CD16/CD32 (FcIII/II
receptor, clone 2.4G2). Cells were then surface stained
for the appropriate markers for 1 h at 4°C, washed three
times with PBS 1% BSA, and fixed in 2% paraformalde-
hyde. Cells were analyzed using a FACScan flow cytom-
eter (Becton–Dickinson). The total number of cells posi-
tive for each marker per mouse was determined by
multiplying the fraction of cells positive for the marker by
the total number of live cells isolated per brain. As
controls, monocytes were incubated with isotype con-
trols and monocytes from the brains of mock-infected
mice were incubated with antibodies to cell markers.
Intracellular IFN- staining
Intracellular IFN- expression in response to peptide
stimulation was performed as previously described (Mu-
rali-Krishna et al., 1998). We cultured 1  106 brain-
derived monocytes/well for 5 h at 37°C in 200 l of RPMI
1640 complete supplemented with 5% FCS, 10 units hu-
man recombinant IL-2, and 1 l/ml Brefeldin A (Golgi-
stop, PharMingen) either with or without epitope pep-
tides. The peptides were used at a concentration of 0.1
g/ml. Cells were then stained as above for surface
expression of CD8 or CD4 and incubated overnight at
4°C. For intracellular IFN- staining cells were then fixed
and permeabilized using the Cytofix/Cytosperm kit
(PharMingen), and stained with a FITC-conjugated
monoclonal rat anti-mouse IFN- antibody (clone XMG
1.2, PharMingen).
Survival assays
RAG1/ and B6 mice were inoculated intracranially
with10 PFU of S4R or SA59R. In two independent experi-
ments, a total of 14 RAG1/ mice were analyzed per
virus, and in parallel a total of 11 B6 mice inoculated with
SA59R and 15 B6 mice inoculated with S4R were analyzed.
Mice were examined for signs of disease or death on a
daily basis up to 21 days postinfection, after which they
were examined every fourth day, and the percentage
survival was calculated.
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